Direxion Daily S&P Biotech Bull 3x Shares Rating $103.28 +2.83 (+2.82%) Closing price 04:10 PM EasternExtended Trading$103.36 +0.08 (+0.08%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.63Holdings in LABU have an aggregate rating of Moderate Buy based on 457 analyst ratings issued in the past year covering 21 companies (24.6% of the portfolio).LABU Aggregate Price Target$103.28High Prediction$103.28Average Prediction$103.28Low Prediction$103.28Holdings in LABU have an aggregate price target of $103.28 and a range of $103.28 to $103.28 covering 21 companies (24.6% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 LABU Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.34%CRSPCRISPR Therapeutics$67.74-7.0%1.7892 of 5 stars2.42$71.50 5.6%191.26%UTHRUnited Therapeutics$453.07+2.2%4.3515 of 5 stars2.67$449.57 -0.8%15Trending NewsInsider Trade1.22%MRNAModerna$28.49+0.4%4.2493 of 5 stars2.00$41.81 46.8%23Options Volume1.21%EXELExelixis$40.09-3.0%4.8183 of 5 stars2.63$44.42 10.8%241.21%ABBVAbbVie$234.07-1.1%4.6282 of 5 stars2.83$228.22 -2.5%30Trending NewsAnalyst Downgrade1.19%MDGLMadrigal Pharmaceuticals$443.01-1.5%4.188 of 5 stars2.73$495.88 11.9%11Analyst Revision1.19%NBIXNeurocrine Biosciences$137.03+0.2%4.8352 of 5 stars2.81$161.89 18.1%21Positive News1.18%HALOHalozyme Therapeutics$68.98-3.8%4.6997 of 5 stars2.38$70.44 2.1%13Trending NewsAnalyst ForecastInsider TradeAnalyst Revision1.18%AMGNAmgen$297.89+0.2%4.5558 of 5 stars2.29$309.70 4.0%21Positive News1.17%NTRANatera$167.35+4.5%3.1286 of 5 stars2.90$192.88 15.3%20Insider Trade1.17%REGNRegeneron Pharmaceuticals$600.004.751 of 5 stars2.79$817.67 36.3%29Positive NewsAnalyst Revision1.15%INSMInsmed$157.16+2.9%3.2066 of 5 stars2.86$149.06 -5.2%21Analyst Forecast1.14%RVMDRevolution Medicines$46.71+2.2%4.2861 of 5 stars2.93$74.64 59.8%151.14%GILDGilead Sciences$112.69+1.9%4.9037 of 5 stars2.90$117.17 4.0%29Positive NewsInsider Trade1.13%INCYIncyte$86.85+0.7%4.5119 of 5 stars2.28$83.64 -3.7%181.13%BMRNBioMarin Pharmaceutical$55.43-0.3%4.9537 of 5 stars2.57$92.60 67.1%23Positive News1.12%BBIOBridgeBio Pharma$52.86-0.8%4.3611 of 5 stars2.89$63.94 21.0%181.12%BIIBBiogen$159.88+3.0%4.4461 of 5 stars2.32$181.24 13.4%311.12%IONSIonis Pharmaceuticals$69.15+1.1%3.3681 of 5 stars2.78$73.88 6.8%18Trending NewsInsider Trade1.12%VRTXVertex Pharmaceuticals$403.30-1.4%4.848 of 5 stars2.62$493.81 22.4%29Trending NewsAnalyst Forecast1.11%ALNYAlnylam Pharmaceuticals$456.35-1.0%4.0989 of 5 stars2.79$439.58 -3.7%29Trending NewsInsider Trade This page (NYSEARCA:LABU) was last updated on 10/3/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LABU Stock Alerts